9-Me-Bc Powder

9-Me-BC or 9-Methyl-β-carboline is a new type of dopaminergic cognitive enhancer. It has been shown to improve DA by inducing the growth of hippocampal dopaminergic neurons (dopamine, a neurotransmitter essential for mood, attention, alertness, and wakefulness).

As of the available scientific literature and chemical databases, specific details regarding the precise mechanism of action and demonstrated efficacy of 9-Methyl-9H-beta-carboline (also known as 9-Me-BC) remain limited. Here is a summary based on preliminary classifications and structural inferences:

1. Chemical Classification and Structural Context

9-Me-BC belongs to the β-carboline family of heterocyclic amines, which are naturally occurring or synthetic compounds with diverse biological activities. Structurally, it is a methylated derivative of β-carboline (norharmane), prepared via the Eschweiler–Clarke reaction on freebase β-carboline. Its molecular formula is C₁₂H₁₀N₂, with a predicted molecular weight of 182.22 g/mol.

2. Proposed Biological Activities (Inferred from β-Carboline Family Traits)

While direct studies on 9-Me-BC are scarce, β-carbolines in general have been associated with interactions with various biological targets, including:

Neuroreceptors: Some β-carbolines modulate serotonin (5-HT) receptors, dopamine receptors, or benzodiazepine binding sites, potentially influencing neurotransmission.

Enzymatic Pathways: Inhibition of monoamine oxidases (MAOs) or other metabolic enzymes, which regulate neurotransmitter levels.

Antioxidant Properties: Certain β-carbolines exhibit free radical scavenging activity, though this has not been specifically confirmed for 9-Me-BC.

3. Reported Applications and Research Scope

9-Me-BC is primarily listed as a research chemical and analytical reference standard, with stated uses limited to laboratory and forensic applications. One source categorizes it as an "nootropic" (cognitive enhancer), noting preliminary observations of improved spatial learning in animal models (rats), though this claim lacks detailed experimental validation in peer-reviewed studies.

4. Key Limitations in Current Data

Critical gaps exist in understanding 9-Me-BC's pharmacodynamics, including:

No published studies definitively describing its molecular targets (e.g., receptor binding affinity, enzyme inhibition constants).

Absence of clinical trials or robust preclinical efficacy data for therapeutic claims (e.g., cognitive enhancement, neuroprotection).

Limited toxicological or safety profiles beyond basic handling precautions for laboratory use.

5. Conclusion

9-Methyl-9H-beta-carboline remains a poorly characterized compound in scientific literature. While its structural similarity to bioactive β-carbolines suggests potential biological activity, specific mechanisms of action and proven efficacy await further research. It is currently restricted to research settings, with no approved medicinal or commercial applications.

9-Me-BC is a known inhibitor of monoamine oxidase A and monoamine oxidase B, and has been proposed for further investigation in the treatment of Parkinson's disease.
It may also possess photosensitizing effects.

Hot selling

Hot Tags: 9-me-bc powder, China 9-me-bc powder manufacturers, suppliers, factory, Melatonin for Healthy Sleep Pattern, Dihydroberberine for Glycemic Control, Sulforaphane for Gut Health Support, Yohimbine Hydrochloride for Energy Boost, ALA for Anti inflammatory Properties, Tetrahydrocurcumin for Anti wrinkle Effects